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Developmental expression of renal angiotensin II receptor genes in the
mouse. The cellular distribution of angiotensin II type 1 (AT1) and type 2
(AT2) receptor mRNA was examined in mouse kidneys at several
embryonic stages (12 to 18 days; 19 days = full term) and up to three
weeks after birth by in situ hybridization. The expression of both AT1 and
AT2 mRNAs appeared simultaneously at 14 days of gestation. However,
their distributions were contrasting: AT1 mRNA was expressed in mature
glomeruli and maturing S-shaped bodies throughout the stages examined.
AT1 expression was also detected at 16 days of gestation in the proximal
and distal tubules and peaked at the end of gestation. Both the temporal
and spatial expression of AT1 coincide with the differentiation and
proliferation of glomerular mesangial and tubular cells during nephrogen-
esis. In contrast, AT2 mRNA was present only in the mesenchymal cells
adjacent to the stalk of the ureter bud at early developmental stages, and,
later, extended to the mesenchymal cells located near, but outside, the
nephrogenic area of superficial cortex and also the cells between collecting
ducts. AT2 expression in these regions decreased markedly within three
weeks after birth. Temporally and spatially, AT2 mRNA expression
coincides with the epithelial-mesenchymal interactions that take place
during early phases of nephrogenesis. The site of AT2 expression also
overlaps closely with that of a specific group of cells which undergo
apoptosis following nephrogenesis. Thus, contrary to current belief, the
activation of AT1 and AT2 genes takes place in different cell types of the
kidney during embryonic development, and thereby conceivably contrib-
utes to the ontogeny of those specific renal cells.
Several investigators have described the developmental expres-
sion of Ang II receptor subtypes in mammalian organs using
nonpeptide angiotensin II (Ang II) receptor antagonists specific
to receptor subtypes, such as losartan (an antagonist of angioten-
sin II type 1 receptor, AT1) and PD123177 (an antagonist of
angiotensin II type 2 receptor, AT2) [1—5]. These studies showed
that AT2 binding sites were present in high densities in many
tissues from relatively early stages of embryonic development.
The interorgan distribution pattern of the binding site was unique
to the fetus and the number of binding sites decreased rapidly and
markedly to an undetectable level shortly after birth. AT1 expres-
sion has also been found in fetal tissues, but only in tissues well
established as Ang II target organs, such as the aorta, kidney, lung
and adrenal gland. Thus, with a few exceptions, such as the brain
[6] and adrenal gland [7], where AT2 is also present in the adult,
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AT2 binding sites are restricted to fetal tissues. This suggests that
AT2 may be involved in cell proliferation and/or differentiation
during fetal development, whereas most of the biological actions
of Ang II known in adults are mediated via AT1, including the
maintenance of circulatory homeostasis and cell proliferation
[8—10].
Given its demonstrated trophic and mitogenic actions on renal
cells, it is reasonable to speculate that Ang II plays an important
role in the ontogenic development of the kidney. Indeed, recent in
vitro studies indicate that Ang II exerts its mitogenic action on a
variety of cell types in the kidney, including mesangial [11—13],
renal arteriolar smooth muscle [14] and distal tubular cells [15].
Recent autoradiographic studies have provided unequivocal
evidence that both AT1 and AT2 are present in mammalian fetal
kidney tissue. In humans, a diffuse pattern of Ang II binding has
been shown throughout the whole kidney of the fetus, except for
the inner medulla, at 21 week gestation. Interestingly, most of the
binding was effectively displaced by an AT2-specific antagonist,
indicating that AT2 predominates over AT1 in the fetal kidney
[16]. In the rat fetal kidney, both AT1 and AT2 binding sites were
observed during kidney development with changes in their pre-
dominance which parallel the processes of nephronogenesis and
tubulogenesis [17].
The recent cloning of both AT1 and AT2 cDNAs has made it
possible to investigate the distribution of each of these receptor
gene transcripts at the cellular level [18—22]. In the present study,
therefore, we attempted to determine whether the change of the
predominance of the receptor subtype from AT2 to AT1 during
fetal kidney development is a phenomenon occurring within the
same cell type. Alternatively, the change represents a phenome-
non where the ontogenic activation of these receptor subtypes
takes place in unique fashions within distinctively different cell
types.
Methods
Mouse tissues
Pregnant C57BL/6 mice were purchased from Harlan Sprague
Dawley, Inc. (Indianapolis, Indiana, USA). Gestational age was
defined to be equal to postcoital days. Mice were sacrificed by
cervical dislocation at various gestational ages (12, 14, 16, 18 days)
and postnatal ages (1 day, 3 weeks). Whole fetuses (gestational 12,
14, 16 days) and kidneys (gestational 18 days, postnatal 1 day and
3 weeks) were then isolated for in situ hybridization.
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Hybridization probes
Two different cRNA probes were used in this study. A 478 bp
EcoR 1/EcoR I fragment in the coding region of mouse AT1A was
subcloned into pSP72 vector, allowing the generation of both
sense and antisense probes. This fragment had a high homology to
mouse AT1B gene (93% homology) and cross-hybridized to
genomic DNA by Southern hybridization, even after high strin-
gency washing. For the mouse AT2 probe, a mouse (Balb/c) fetal
eDNA library was screened using rat AT2 cDNA fragment which
corresponds to nucleotide 358 to 1467 [22] as a probe. The cloned
mouse AT2 eDNA consists of 2871 bp and contains the entire
protein coding region, as well as 5'- and 3'-nontranslated regions
[23]. The 436 bp Ssp I/Nsi I fragment in the protein coding region
was subcloned into pSP72 vector. This fragment had an extremely
low homology (<30%) to mouse AT1A and AT1B genes and did
not cross-hybridize to these genes by Southern analysis. After
linearization, single-stranded sense and antisense RNA probes
were synthesized in the presence of [a-35S] UTP (1135 Ci/mmol,
DuPont NEN, Research Products, Boston, Massachusetts, USA)
using either T7 or Sp6 RNA polymerase. Specific activities were
2>< io dpm/g RNA.
In situ hybridization
Tissues were fixed overnight in 4% paraformaldehyde/phos-
phate-buffered saline (PBS) at 4°C, processed routinely, embed-
ded in paraffin and stored at 4°C until used for hybridization
studies.
The in situ hybridization protocol was performed as described
previously with slight modifications [24]. Three micrometer sec-
tions were cut and placed on 2% 3-aminopropyltriethoxysilane-
coated glass slides. Sections were dewaxed in xylene, then hy-
drated serially in 100% to 30% ethanol. They were refixed in 4%
paraformaldehyde for 20 minutes, washed in PBS, and then
treated with 20 g/ml proteinase K for five minutes, Subsequently,
sections were acetylated with 0.4% (vol/vol) acetic anhydride in
0.1 M triethanolamine for 10 minutes twice. After rinsing in PBS,
sections were successively dehydrated in 30% to 100% ethanol
and air-dried.
Sections were covered with 60 to 100 d of hybridization
mixture containing 35S-labeled cRNA probe (2 X i04 cpm/d),
50% deionized formamide, 10% dextran sulfate, 8 mM DTF, 0.2
mg/mi tRNA, 0.02% Ficoll and 0.02% BSA, then incubated
overnight at 50°C in a sealed humidified container. After hybrid-
ization, the slides were washed in 50% formamide, 2 X SSC (300
mM NaCl, 30mM sodium citrate, pH 7.0), 100 mtvi DIT at 65°C for
20 minutes, and treated with 20 g/ml RNase A at 37°C for 30
minutes. Sections were washed in 2 X SSC, followed by 0.1 X SSC
at 65°C, dehydrated in 30% to 100% ethanol with 0.3 M ammo-
nium acetate, and air-dried. They were dipped in photographic
emulsion (Ilford K2 emulsion; Ilford Ltd., Basildon, Essex, UK)
diluted in 2% glycerol solution, air-dried, and exposed at 4°C for
15 to 30 days. After development with D-19 developer, the slides
were counterstained with 0.02% toluidine blue.
Results
To investigate AT1 and AT2 mRNA distribution during kidney
development, sections of whole mouse fetuses and/or kidneys at
different gestational stages were hybridized with respective anti-
sense cRNA probes. Sense cRNA probes for both AT1 and AT2
were also used to assess the background signals derived from each
probe. Hybridization with the sense AT2 cRNA showed extremely
low background, while hybridization with the sense AT1 cRNA
showed a low and homogeneous background pattern in all
experiments (Fig. 4 c, d).
At 12 days of gestation, when migration of some branches of the
ureter bud was evident in the metanephric blastema, specific
hybridization signals for both AT1 and AT2 were undetectable in
this area. In contrast, intense signals for AT2 (but not AT1) were
noted in mesenchymal cells surrounding the mesonephric duct
and tubules (Fig. 1). Although most organs lack appreciable
signals for both AT1 and AT2, AT2 mRNA was distributed in the
skin, tongue and undifferentiated mesenchymal cells (not shown).
At 14 days of gestation, signals of AT1 mRNA were now found
over the adrenal gland and the liver (Fig. 2a). Spotty signals were
also found in the metanephros with an intensity clearly higher
than the background. In contrast, abundant signals of AT2 mRNA
were present in the skin, diaphragm, adrenal gland (the outer part
of cortex and medulla), metanephros and the undifferentiated
mesenchymal and connective tissues (Fig. 2d). In addition to
these, intense AT2 signals were still present in the regressing
mesonephros. In other sections, intense signals could also be seen
in the tongue. At this stage, with high magnification, precise
distribution of both AT1 and AT2 mRNAs was demonstrable in
the metanephros. Several nephrogenic areas consisting of vesicles,
comma-shaped or S-shaped bodies were seen along with a small
number of primitive glomeruli. The branches of the ureter and
collecting ducts rising from the ureter bud were also seen at this
stage. AT1 transcripts were present only in the central primitive
glomeruli, but not in S-shaped bodies or in other structures (Fig.
2 b, c). In contrast, AT2 expression was present within the capsule
and mesenchymal cells which surround the ureter branches,
whereas no AT2 signals were detectable in the nephrogenic area
or the ureteric epithelial cells (Fig. 2 e, f).
At 16 days of gestation, the cortical and medullary regions were
well delineated. Although not arranged in an organized fashion,
proximal and distal convoluted tubules began to appear at this
stage. Again, signals for AT1 were present in the mature glomer-
uli and maturing S-shaped bodies in the juxtamedullary region,
but not in S-shaped bodies located in the outer part of the cortex
(that is, preformed glomeruli; Fig. 3a). Weak AT1 signals, barely
distinguishable from background, could also be seen diffusely over
the region where proximal and distal convoluted tubules are
located. Signals for AT2 were distributed in the mesenchymal
cells along the papillary duct and between collecting ducts, as well
as in the renal capsule (Fig. 3 b, c, d). In addition, AT2 signals
were present in the undifferentiated mesenchymal cells in the
region subjacent to the renal capsule.
At 18 days of gestation, in addition to the presence of a large
number of glomeruli, the cortical region contained numerous
proximal and distal convoluted tubules. Although not shown, the
expression patterns for both AT1 and AT2 were similar to those
at day 16, but the levels of AT1 signal overlying proximal and
distal tubules were now higher and distinctively above back-
ground.
On the day of birth, the basic architecture of the adult kidney
has already formed, yet maturation continues postnatally for
approximately 20 days in the mouse. At this stage, the distribution
pattern of AT1 mRNA was distinctively different from that of
AT2 mRNA. Thus, the cortical region, except for the superficial
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Fig. 1. AT2 mRNA expression in the mouse fetus at 12 days of gestation. Intense signals were present in the mesenchymal cells surrounding mesonephric
tubules (mt) (x42.5).
area which contained the remnant nephrogenic zone and the
medullary ray, had strong signals for AT1 (Fig. 4a). It could be
seen that mature glomeruli had much more intense signals than
the proximal and distal tubules (Fig. 5),while the medulla and the
papilla did not have appreciable levels of signal. In contrast, the
capsule, the medullary region, and the medullary ray extending
into the cortex had distinctive AT2 signals. These signals overlay
the cells along the collecting duct (Fig. 4b). A low level of AT2
signal was detectable in the superficial cortex. Cells surrounding
the papillary duct had no detectable signal.
In three-week-old kidneys, we observed a pattern of AT1
distribution that is identical to that observed previously in adult
rats (that is, intense signals in glomeruli and relatively weak
signals in proximal tubules) [24], whereas no signal was detectable
for AT2 at this stage (not shown).
Discussion
To investigate the ontogeny of renal AT1 and AT2 distribution
at the cellular level, we employed in situ hybridization. Protein
coding regions of AT1A and AT2 were used to synthesize cRNA
probes specific to the corresponding gene transcripts. Our recent
in situ hybridization study [25] using both AT1A- and AT1B-
specific probes in adult animals showed a pattern of AT1A
distribution that was identical to that documented in a previous
study [24] in which a single probe homologous to both AT1A and
AT1B was used. Thus, intense signals were detected primarily
within glomeruli, with relatively weak signals in proximal tubules.
Also, only an extremely low level of AT1B expression was
detected and localized within glomeruli. Therefore, it appeared
technically difficult to ascertain the precise distribution of AT1B
in the kidney because of its low level of expression. For this
reason, we chose in the present study to use as an AT1 probe an
AT1A protein coding region which is highly homologous (93%) to
that of AT1B. Indeed, this probe was shown to detect specifically
both AT1A and AT1B genomic DNA fragments with high
sensitivity by Southern hybridization, even after high-stringency
washing (data not shown).
In the present study, we found abundant signals of AT2 mRNA
in the skin, diaphragm, adrenal gland, metanephros and the
undifferentiated mesenchymal and connective tissues in the
mouse fetus, while the distribution of AT1 mRNA was found in
the adrenal gland, liver and kidney. These whole body distribution
patterns duplicate those demonstrated previously by binding
assays. Within the kidney, we found distinctively different patterns
of cellular distribution for AT1 versus AT2 gene transcripts at
several different stages of embryonic development and immedi-
ately after birth. Both AT1 and AT2 mRNAs were expressed in
the metanephros virtually simultaneously at 14 days of gestation,
when vigorous branching of the ureter bud could be seen preced-
ing the appearance of the new nephrogenic zone. However, the
dynamic cellular pattern of expression that occurred during
kidney development was distinct for each receptor type. More-
over, AT1 expression continues throughout adult life, whereas
AT2 expression decreases markedly within three weeks after
birth. Thus, in the fetal kidney, the expression of AT1 mRNA was
seen primarily in mature glomeruli and maturing S-shaped bodies.
In addition, AT1 mRNA was expressed in the proximal and distal
tubules later in developing kidneys with an intensity higher than
that in the adult. In contrast, AT2 mRNA was expressed primarily
in mesenchymal cells which are adjacent to the stalk of the ureter
epithelium at early developmental stages. Later, the expression
extended to the mesenchymal cells located near the nephrogenic
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Fig. 2. Expression ofATi andAT2 mRNA in the whole mouse fetus (a, d) and the metanephros (b, c, e, f) at 14 days of gestation. AT1 mRNA was expressed
over the adrenal gland and the liver; mRNA was also found in the metanephros as spotty signals (a). These spotty signals were present predominantly
in the mesangial region of maturing glomeruli (g), but not in S-shaped bodies (s) (b, c). In the adjacent section, intense signals of AT2 mRNA were
found in the skin, diaphragm, the outer part of the adrenal cortex, the adrenal medulla, metanephros, mesonephros (regressing) and the undifferentiated
mesenchymal and connective tissues throughout the entire fetus (d). In the metanephros, AT2 mRNA was present in the undifferentiated mesenchymal
cells surrounding ureter branches and within the capsule (e, f). (a and d, X8.5; b and e, X85; c and 1, X 170) Numbers represent: 1, skin; 2, forelimb;
3, heart; 4, lung; 5, liver; 6, diaphragm; 7, stomach; 8, adrenal gland; 9, metanephros; 10, mesonephros; 11, hind limb.
area of the superficial cortex and the area between collecting medulla at 20 days of gestation and in new born rat kidneys.
ducts. Tufro-McReddie et al [26] showed by in situ hybridization with a
Using binding autoradiography, Ciuffo et al [17] reported that probe common to both AT1A and AT1B that signals were present
AT1 is localized in the glomeruli of the juxtamedullary region, but in glomeruli and mature tubules of the inner cortex and nephro-
not of the superficial nephrogenic area, in tubules or in the genic area of the outer cortex. Shanmugam et al [27] has also
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Fig. 3. AT] (a) andAT2 (b, c, d) mRNA at 16 days of gestation. AT1 mRNA was mainly seen in mature glomeruli, and weak signals appeared diffusely
in the region of proximal and distal tubules. AT2 mRNA was present in the mesenchymal cells along the papillary duct (pd) and between collecting ducts
(Cd). (a and b, X42.5; c and d, x170)
shown with both AT1A and AT1B probes that the signals were
present in mature glomerular mesangial cells, mesenchymal cells
in the nephrogenic area and surrounding tubules in the rat kidney
at 19 days of gestation. Thus, all the studies, including our
previous [24] and present studies, uniformly demonstrated ATI
mRNA localization in mature glomeruli. Also some, but not all,
studies documented AT1 mRNA expression in the nephrogenic
area. A study using wide-field electronmicroscopy has docu-
mented mesangial cell differentiation occurring early in glomeru-
logenesis [28]. This study illustrates the pattern of glomerular
formation; Capillaries from the vascular system extend into
S-shaped bodies, and at a later phase, mesangial cell differentia-
tion occurs from the primitive pericyte of the immature capillary,
although the possibility has not been ruled out that the glomerular
mesangium originates from nephrogenic mesenchyme per se [29].
In this context, the timing of AT1 expression in the immature
glomeruli observed in our study appears to coincide with mesang-
ial cell differentiation from the primitive pericyte. Interestingly, it
has been shown recently in vitro that Ang II exerts potent
mitogenic actions on mesangial cells isolated from the fetus, but
not those from the adult under static culture conditions [11].
Taken together, it is conceivable that Ang II participates in the
differentiation and/or the proliferation of glomerular mesangial
cells during nephrogenesis through AT1, and once glomeruli have
matured, AT1 channels the vasoconstriction and other physiologic
and pathophysiologic functions of Ang II, as AT1 mRNA expres-
sion in the glomerulus remains at a high level throughout adult-
hood.
The trophic effect of Ang II on cultured proximal tubule
epithelial cells has been documented by several investigators [30,
31], and a recent in vitro study [15] has demonstrated proliferative
and growth-promoting effects of Ang II on cultured thick ascend-
ing limb cells via AT1. More recently, an important role for Ang
II action during the first postnatal week has been elucidated [32].
When rats were treated with an angiotensin I converting enzyme
inhibitor or an AT1 antagonist at three days of age for the
subsequent 15 days, irreversible histopathologic renal abnormal-
ities, such as tubulointerstitial inflammation, papillary atrophy
and pelvic dilation were induced. These abnormalities were,
however, not inducible by an AT2 antagonist. These results may
reflect important actions of Ang II on the morphogenesis of renal
tubule cells via AT1. In the present study, we showed a qualita-
tively higher level of AT1 mRNA expression in the proximal and
distal tubules at later stages of developing kidneys than the
typically weak expression in the adult. The possibility therefore
exists that, in the proximal and/or distal tubules, Ang II may have
a role in cell growth via AT1, especially at late stages of kidney
development.
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Fig. 4. Distinctive distribution pattern ofATi (a) and AT2 (b) mRNA. Intense AT1 mRNA signals were present in the cortex (but not in the superficial
region) and in the outer medulla, whereas signals of AT2 mRNA were located in the inner medulla and within the renal capsule. Hybridization with
the sense AT1 cRNA showed a low and homogeneous background (c), while hybridization with the sense AT2 probe showed an extremely low
background (d) (x42.5).
nephric development is thought to be an inductive interaction
between the ureter bud and the mesenchyme, that is, the so-called
"epithelial-mesenchymal interactions," and nephric units are
formed as a result of repetitive branching of the ureter epithelia
which accompanies formation of new condensate from the mes-
enchyme adjacent to the ureter. Although most organs require an
epithelial branching process during ontogenic development, the
kidney uses a unique branching strategy. Thus, while some
portions of the mesenchyme are required for continued branching
of the ureter bud and remain as undifferentiated stroma, other
portions proceed to differentiate to epithelia.
Many factors such as growth factors, extracellular matrix, cell
adhesion molecules and gangliosides are thought to be involved in
the epithelial-mesenchymal interactions [37]. Of interest, Sariola
et al reported that the undifferentiated mesenchymal cells adja-
Fig. 5. A Ti mRNA expression on the day of birth. AT1 mRNA was cent to the stalk of ureter stain with antibodies to a surface
expressed intensely in the mature glomeruli, and also in the proximal and ganglioside G03, whereas the rest of the mesenchyme and ureter
distal tubules (X 170). epithelia are negative [38]. Antibodies to GD3 can effectively block
the formation of new branching of ureter bud. It was therefore
suggested that there are two distinctive cellular lineages of the
Two separate tissue components are required for the initiation metanephric mesenchyme, namely mesenchyme with an epithelial
of embryonic kidney development: the metanephric mesenchyme bias and mesenchyme with an interstitial bias. In this regard, we
and the ureter epithelium [33—361. The initial trigger for meta- observed expression of AT2 in undifferentiated mesenchymal cells
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adjacent to the stalk of the ureter epithelium, located in the
superficial cortex near nephrogenic areas and in the area between
collecting ducts. AT2 expression was not found in the condensed
area of mesenchyme or in the ureter epithelium itself. Thus, the
AT2 distribution pattern found in the present study duplicates
that for GDS described above, suggesting that AT2 expression is
closely associated with the cell type which becomes the interstitial
cell in the adult. Although in our study we could not find AT2
expression in the interstitium in adult kidneys (data not shown), it
is conceivable that the AT2 gene may be reactivated in those cells
with pathogenic interstitial proliferative processes.
Recently, Koseki, Herzlinger and Al-Awqati [39] have shown
that when embryonic mesenchyme in the rat kidney was induced
in vitro and in vivo, many cells surrounding the new epithelia
showed morphological evidence of programmed cell death, that is,
'apoptosis' [40], such as condensed nuclei, fragmented cytoplasm
and cell shrinking. These cells undergoing apoptosis were distrib-
uted within the undifferentiated mesenchyme adjacent to the
induced mesenchyme, but not in the undifferentiated mesen-
chyme in other regions. The distribution pattern of AT2 also
overlaps that of these cells. We also found abundant AT2
expression in the mesenchyme of mesonephros at 12 days of
gestation. At this stage, this structure is particularly prominent,
but the mesonephros starts regression shortly thereafter. We
could detect a high level of AT2 expression also at 14 and 16 days
of gestation, although the size of mesonephros had already
decreased substantially. These lines of evidence point to the
interesting possibility that AT2 expression may represent a group
of specific cells which are programmed to undergo apoptosis.
In the present study, we found a distinct cellular distribution
pattern of AT1 versus AT2 during kidney development. A tran-
sition of expression from one receptor subtype to another was not
found to occur within the same cell types; rather, the two receptor
subtypes appear in different cell types.' Although the functional
role of AT1 and AT2 during kidney development remains to be
elucidated by studies selectively inhibiting these receptors, our
morphologic analysis at the mRNA level suggests that both AT1
and AT2 may participate in the distinctive ontogenic development
of different renal cell types.
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'Ciuffo et al reported earlier, in rats, that AT2 binding sites were
present in immature structures of the nephrogenic area at early develop-
mental stages. This was followed by concurrent disappearance of AT2 and
new appearance of AT1 within maturing/matured glomeruli [171. In the
present study, we could not find any significant AT2 mRNA signals in the
nephrogenic area, or a transition of expression from AT2 to AT1 within
the same region during any stages of renal development. Given the recent
redefinition of AT2 based on its nucleotide sequence (rather than the
earlier one on binding assays with various synthetic compounds), it is
anticipated that some discrepancy may arise between the results from
mRNA assays and binding experiments. Please note that the pattern of
binding is variable among the synthetic compounds of the same class [41].
With the exception of the above, our results were in close agreement in
many respects with several previous studies using binding autoradiogra-
phy.
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